FDA Accepts Pfizer’s Supplemental New Drug Applications for BRAFTOVI + MEKTOVI
Biospace,
sNDAs are supported by results from the PHAROS trial, evaluating the combination in BRAF V600E-mutant metastatic non-small cell…
sNDAs are supported by results from the PHAROS trial, evaluating the combination in BRAF V600E-mutant metastatic non-small cell…
sNDAs are supported by results from the PHAROS trial, evaluating the combination in BRAF V600E-mutant metastatic non-small cell…
Published on: Pancreatic cancer remains elusive with extremely low survival rates.
Promoting safe and effective cancer care delivery warrants consideration of factors beyond the care provided in the clinic.
All members of the biopharma industry should call on Congress to reauthorize FDA user fees this month, before their expiration…
Lung Cancer Awareness Month (LCAM)is dedicated to promoting symptom awareness to support early diagnosis and highlighting the…
Stage 2 lung cancer is when the tumor has grown to a certain size, or the cancer may have spread beyond the lungs and into the…
Small-cell lung cancer (SCLC) is a form of lung cancer that is challenging to treat.
June 27, 2021 6 min read Source/Disclosures Published by: Source: Healio Interview Disclosures: Lovly reports no relevant…
Cancer is a major public health problem. Since 2015, it has claimed more than 9 million lives each year.
Herbst can remember going on rounds with Nachman as a young physician, seeing patients with Hodgkin lymphoma and review-ing the…
Public and private investments made in cancer research in recent decades are paying dividends — with interest — as today’s…
This transcript has been edited for clarity. Hello. It's Mark Kris from Memorial Sloan Kettering, here to give my top 10…
This transcript has been edited for clarity. Hello. This is Mark Kris from Memorial Sloan Kettering, speaking today about a…
In 2020, a new “big C” crashed into our consciousness. At the peak of its surge in the spring, COVID-19 killed more people per…
Es tut sich viel in der Onkologie – bei steigenden Patientenzahlen. Für 2020 erwartet das RKI 510.000 Krebs-Neudiagnosen, die Häl…
Cancer drug approvals between 2000 and 2016 were associated with a significant reduction in deaths from the most common cancers…
Cancer drug approvals between 2000 and 2016 were associated with a significant reduction in deaths from the most common cancers…
Es tut sich viel in der Onkologie – bei steigenden Patientenzahlen. Für 2020 erwartet das RKI 510.000 Krebs-Neudiagnosen, die Häl…
More than 1.2 million people in the US prevented facing death following a cancer diagnosis, between the year 2000 and 2016…
Credit: CC0 Public Domain More than 1.2 million people in the US prevented facing death following a cancer diagnosis, between…
More than 1.2 million people in the US prevented facing death following a cancer diagnosis, between the year 2000 and 2016…
More than 1.2 million people in the US prevented facing death following a cancer diagnosis, between the year 2000 and 2016…
Im aktuellen Onko-Blog geht es um eine sehr erfolgreiche Erstlinienbehandlung der ALL ohne Chemotherapie.
Es tut sich viel in der Onkologie – bei steigenden Patientenzahlen. Für 2020 erwartet das RKI 510.000 Krebs-Neudiagnosen, die Häl…
Im aktuellen Onko-Blog geht vor allem um hämatologische Tumore: Um die Resterkrankung nach AML-Therapie, CAR-T-Zellen beim B-Zell…
Es tut sich so viel in der Onkologie – und dies bei steigenden Patientenzahlen.
Es tut sich so viel in der Onkologie – und dies bei steigenden Patientenzahlen.
Es tut sich so viel in der Onkologie – und dies bei steigenden Patientenzahlen.
Es tut sich so viel in der Onkologie – und dies bei steigenden Patientenzahlen.
CARLSBAD, Calif: The U.S. Food and Drug Administration (FDA) has granted premarket approval to Thermo Fisher Scientific's…
FDA has granted premarket approval to Thermo Fisher Scientific’s Oncomine Dx Target Test as a companion diagnostic (CDx) to…
Share on Pinterest The latest research shows that lung cancer deaths have been decreasing over the past decade and that’s…
Research published last month in The New England Journal of Medicine shows that lung cancer deaths have been decreasing and…
CDx approval expands clinical utility of Oncomine Dx Target Test to identify candidates for GAVRETO Sep 8, 2020 The Oncomine Dx…
It is now also the first and only FDA-approved test of its kind for a targeted treatment for RET fusion-positive NSCLC.
CDx approval expands clinical utility of Oncomine Dx Target Test to identify candidates for GAVRETO CARLSBAD, Calif.
CARLSBAD, Calif., Sept. 8, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has granted premarket approval to…
, /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has granted premarket approval to Thermo Fisher Scientific's…
CDx approval expands clinical utility of Oncomine Dx Target Test to identify candidates for GAVRETO CARLSBAD, Calif.
CARLSBAD, Calif., Sept. 8, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has granted premarket approval to…
FDA Approves First NGS-Based Companion Diagnostic for RET Fusion-Positive Non-Small Cell Lung Cancer CDx approval expands…
CARLSBAD, Calif., Sept. 8, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has granted premarket approval to…
CDx approval expands clinical utility of Oncomine Dx Target Test to identify candidates for GAVRETO CARLSBAD, Calif.
Es tut sich so viel in der Onkologie – und dies bei steigenden Patientenzahlen.
CARLSBAD, Calif., Sept. 8, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has granted premarket approval to…
Here are what the editors at HealthDay consider to be the most important developments in Infectious Disease for August 2020.
Here are what the editors at HealthDay consider to be the most important developments in Pediatrics for August 2020.
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for August 2020.
Here are what the editors at HealthDay consider to be the most important developments in Pathology for August 2020.
Here are what the editors at HealthDay consider to be the most important developments in Pulmonology for August 2020.
Es tut sich so viel in der Onkologie – und dies bei steigenden Patientenzahlen.
58 名の先生が役に立ったと考えています。 米国で肺がんの死亡率が低下している。米国立がん研究所(NCI)のNadia Howlader氏らが全米の死亡登録とがん登録のデータをリンクさせて解析した結果、小細胞肺がん(SCLC)の死亡率低下は発生率の低下と一致…
/Crystal light, stock.adobe.com Bethesda/Maryland Die verbesserten Therapieergebnisse beim nicht-kleinzelligen Lungenkrebs (NSCLC…
Es tut sich so viel in der Onkologie – und dies bei steigenden Patientenzahlen.
Death rates for the most common type of lung cancer have fallen significantly in the United States in recent years, an…
Mortality rates from non-small cell lung cancer (NSCLC) have significantly declined in the United States in recent years.
Lung cancer mortality rates have significantly dropped in the recent years because of more advanced treatments, according to a…
"Reduced tobacco consumption in the U.S. has been associated with a progressive decrease in lung cancer deaths that started…
KEY POINTS Researchers found a significant drop in lung cancer mortality rates in recent years Survival from non-small cell…
According to a new study, mortality rates from the most common lung cancer, non-small cell lung cancer (NSCLC), have fallen…
Mortality from non–small cell lung cancer (NSCLC) has fallen sharply in the United States over the past few years, and survival…
Death rates for the most common type of lung cancer are on the decline, likely due to a decrease in incidence and advance in…
Patients with the most common type of lung cancer, non-small cell lung cancer, are surviving longer, according to a new study.
Oncology/Hematology > Lung Cancer Decline accelerated after approval of targeted agents, immunotherapy for lung cancers…
WEDNESDAY, Aug. 12, 2020 (HealthDay News) — Mortality from non-small-cell lung cancer (NSCLC) in the United States fell sharply…
Jason Mast Associate Editor Does precision medicine work? The approach, based on finding a drug to target a patient’s…
WEDNESDAY, Aug. 12, 2020 (HealthDay News) -- Mortality from non-small-cell lung cancer (NSCLC) in the United States fell…
Death rates from lung cancer have been declining sharply in the US due to recent advances in treatments, a new study suggests.
Death rates from lung cancer have been declining sharply in the US due to recent advances in treatments, a new study suggests.
According to a new study, mortality rates from the most common lung cancer, non-small cell lung cancer (NSCLC), have fallen…
According to a new study, mortality rates from the most common lung cancer, non-small cell lung cancer (NSCLC), have fallen…
1. In this retrospective cohort study, there was an observed decrease in mortality in non-small-cell lung cancer patients that…
Death rates from lung cancer have been declining sharply in the US due to recent advances in treatments, a new study suggests.
What to watch next Click to expand Lung cancer is the leading cause of cancer death in the United States, but a study found…
Death rates from lung cancer have been declining sharply in the US due to recent advances in treatments, a new study suggests.
Death rates from lung cancer have been declining sharply in the US due to recent advances in treatments, a new study suggests.
Source: US Department of Health and Human Services – 2 News Release Wednesday, August 12, 2020 According to a new study…
Aug. 12 (UPI) -- Deaths from non-small cell lung cancer in the United States declined by about 3% a year on average between…
2 min read Source/Disclosures Disclosures: Howlader reports no relevant financial disclosures.
Lung cancer is the leading cause of cancer death in the United States, but a study found that mortality rates have plummeted…
Lung cancer is the leading cause of cancer death in the United States, but a study found that mortality rates have plummeted…
Lung cancer is the leading cause of cancer death in the United States, but a study found that mortality rates have plummeted…
Lung cancer is the leading cause of cancer death in the United States, but a study found that mortality rates have plummeted…
Lung cancer is the leading cause of cancer death in the United States, but a study found that mortality rates have plummeted…
Lung cancer is the leading cause of cancer death in the United States, but a study found that mortality rates have plummeted…
Lung cancer is the leading cause of cancer death in the United States, but a study found that mortality rates have plummeted…
Lung cancer is the leading cause of cancer death in the United States, but a study found that mortality rates have plummeted…
Two-year survival rates are rising, according to the National Cancer Institute National Cancer Institute researchers said new…
Lung CA seen on CXR. Credit: James Heilman, MD/Wikipedia According to a new study, mortality rates from the most common lung…
Mortality from non–small cell lung cancer (NSCLC) has fallen sharply in the United States over the past few years, and survival…
News Professional WEDNESDAY, Aug. 12, 2020 -- Mortality from non-small-cell lung cancer (NSCLC) in the United States fell…